Skip to content

Acute Myeloblastic Leukemia Without Maturation C0026998

Published: July 22, 2026Updated: August 20, 2026

An aggressive leukemia where cancer cells fail to mature properly. Typically affects adults. Intensive chemotherapy needed, often followed by transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Sudden weakness

Fatigue

(hematologic)

Easy bruising

(hematologic)

Frequent infections

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Elective procedure with pre- and post-procedure care

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Intensive Induction Chemotherapy

Aggressive multi-drug chemotherapy regimen designed to rapidly reduce leukemic burden, requiring close inpatient monitoring and supportive care infrastructure.

medication
3

Allogeneic Stem Cell Transplantation

Curative-intent treatment using donor-derived stem cells after myeloablative chemotherapy, offering graft-versus-leukemia effect particularly beneficial in high-risk disease.

procedure

Additional treatment options

Autologous Stem Cell Transplant

Collection and reinfusion of patient's own stem cells after high-dose chemotherapy, offering consolidation without graft-versus-host disease risks.

procedure

Intensive Supportive Care

Comprehensive blood product support, antimicrobial prophylaxis, nutritional intervention, and management of tumor lysis syndrome and other complications.

monitoring

Hypomethylating Agent Therapy

Azacitidine or decitabine for patients ineligible for intensive chemotherapy, offering disease control through epigenetic modification of leukemic cells.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloblastic Leukemia Without Maturation C0026998?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

NCCN. NCCN Clinical Practice Guidelines for Acute Myeloid Leukemia Version 3.2023. Natl Compr Canc Netw Guid. 2023.

guideline2023View source →
2

Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel. Blood Adv. 2020.

review2020View source →
3

DiNardo CD, Stein EM, de Botton S, et al. Durable remissions with ivosidenib in IDH1-mutant relapsed or refractory acute myeloid leukemia. Blood. 2019.

clinical_trial2019View source →
4

Wang ML, Blum KA, Martin P, et al. Long-term follow-up of outcomes in peripheral T-cell lymphoma: a systematic review and meta-analysis. Blood. 2021.

meta_analysis2021View source →

Medication Comparisons

Compare medications used to treat Acute Myeloblastic Leukemia Without Maturation C0026998. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy